Earning Analysis
Welcome to our in-depth analysis of Elutia Inc(ELUT) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Elutia Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q3 | 2025-11-06 | After Hours | -0.15 | -0.19 | -26.67 | 6.65M | 3.32M | -50.03 | -5.00 | -21.44 |
| FY2025Q2 | 2025-08-14 | After Hours | -0.17 | -0.26 | -52.94 | 6.55M | 6.26M | -4.38 | -6.05 | -1.40 |
| FY2025Q1 | 2025-05-08 | After Hours | -0.27 | -0.21 | +22.22 | 6.65M | 6.03M | -9.32 | +4.52 | -13.57 |
| FY2024Q4 | 2025-03-06 | After Hours | 0.00 | -0.26 | - | 5.90M | 5.47M | -7.32 | +8.82 | +27.45 |
| FY2024Q2 | 2024-08-07 | After Hours | - | - | - | 6.65M | 6.29M | -5.40 | +8.10 | +16.20 |
| FY2024Q1 | 2024-05-09 | - | - | -0.75 | - | 6.10M | 6.69M | +9.74 | -4.11 | +12.33 |
| FY2023Q4 | 2024-03-07 | - | - | -0.66 | - | 6.55M | 5.88M | -10.31 | +1.70 | -15.30 |
| - | 2022-11-14 | - | -0.66 | -0.73 | -10.61 | - | - | - | +1.12 | -6.15 |
| - | 2022-08-11 | - | -0.55 | -0.69 | -25.45 | - | - | - | - | +20.31 |
| - | 2022-05-09 | - | -0.62 | -0.60 | +3.23 | - | - | - | -2.73 | -5.98 |
ELUT Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Elutia Inc reported performance for FY2025Q3, announced on 2025-11-06. The company achieved an EPS of -0.19, compared to analyst estimates of -0.15 by -26.67% . Revenue for the quarter reached 3.32M compared to expectations of 6.65M by -50.03% .
The stock price reacted with a -5.00% one-day change and a -21.44% five-day change following the earnings release. These movements reflect market reaction in Elutia Inc growth trajectory and strategic initiatives.
ELUT Earnings Forecast
Looking ahead, Elutia Inc(ELUT) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 3.10M and an EPS of -0.12.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -31%, while EPS estimates have been Revise Downward by -34.56%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -60.76% . These revisions correlate with a -63.17% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Elutia Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between ELUT's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward
-31%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-34.56%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
-60.76%
In Past 3 Month
Stock Price
Go Down
-63.17%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:18.70M
--
EPS Estimate-Annual FY 2025:-0.45
—
Stock Price0.69
ELUT Revenue and EPS Performance: A Historical Perspective
Elutia Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-06,After Hours):
EPS: -0.19 (Actual) vs.-0.15 (Estimate) (-26.67%)
Revenue: 3.32M (Actual) vs. 6.65M (Estimate) (-50.03%)
Price Reaction: -5.00%(1-Day), -21.44%(5-Day)
FY2025Q2 (2025-08-14,After Hours):
EPS: -0.26 (Actual) vs.-0.17 (Estimate) (-52.94%)
Revenue: 6.26M (Actual) vs. 6.55M (Estimate) (-4.38%)
Price Reaction: -6.05%(1-Day), -1.40%(5-Day)
FY2025Q1 (2025-05-08,After Hours):
EPS: -0.21 (Actual) vs.-0.27 (Estimate) (22.22%)
Revenue: 6.03M (Actual) vs. 6.65M (Estimate) (-9.32%)
Price Reaction: 4.52%(1-Day), -13.57%(5-Day)
Earnings Reaction
The chart below shows how ELUT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ELUT sees a +6.48% change in stock price 10 days leading up to the earnings, and a +1.33% change 10 days following the report. On the earnings day itself, the stock moves by -1.50%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -5.00% on the day following the earnings release and then changed by -34.73% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Elutia Inc (ELUT) Q3 2025 Earnings Call Summary
Positive
2025-11-06
The earnings call reflects a positive sentiment due to improved financial metrics, including increased gross margins and reduced operating expenses. The strategic sale of the bioenvelope business significantly strengthened the cash position. Despite some revenue declines, the company regained control over product lines, showing potential for future growth. The Q&A session highlights management's proactive approach in leveraging existing relationships and infrastructure for new product launches. Overall, the financial health and strategic initiatives suggest a positive outlook for the stock price in the short term.
Elutia Inc (ELUT) Q2 2025 Earnings Call Summary
Neutral
2025-08-14
The earnings call reveals mixed signals: strong revenue growth in BioEnvelope and cardiovascular products, but a significant EBITDA loss and cash constraints. Positive developments include improved gross margins and EluPro's expansion, but financial risks and competitive pressures remain. The Q&A session highlighted management's cautious approach to business updates and regulatory pathways, which may concern investors. Overall, the sentiment is balanced by growth potential and financial challenges, leading to a neutral prediction.
Elutia Inc (ELUT) Q4 2024 Earnings Call Summary
Negative
2025-03-08
The earnings call reveals mixed signals: while there are positive aspects like the EluPro launch, strategic partnerships, and improved gross margins, these are overshadowed by declining revenues, increased cash usage due to lawsuits, and economic challenges affecting sales. Additionally, the lack of a shareholder return plan and management's vague responses in the Q&A add to uncertainties. The competitive market and operational challenges further complicate the outlook, suggesting a likely negative stock price reaction over the next two weeks.
Elutia Inc (ELUT) Q4 2024 Earnings Call Summary
Negative
2025-03-06
The earnings call reveals several concerns: a significant operational loss, financial risks, and supply chain challenges. Despite some positive factors like the distribution agreement with Boston Scientific and improved gross margins, the lack of clear guidance, ongoing litigation, and financial losses overshadow these. The Q&A section highlighted uncertainties regarding distribution timelines and account growth. Overall, these factors suggest a negative sentiment, likely leading to a stock price decrease in the short term.
Elutia Inc. (ELUT) Q3 2024 Earnings Call Summary
Positive
2024-11-15
The earnings call reveals strong financial performance with significant year-over-year growth in revenue, gross margin, operating income, and net income. The share buyback program adds further positive sentiment. Despite some risks and uncertainties, the company's optimistic guidance, strategic initiatives, and market expansion efforts suggest a positive stock price movement over the next two weeks.
Elutia Inc. (ELUT) Q2 2024 Earnings Call Summary
Positive
2024-08-10
The earnings call indicates strong product development and market opportunities, particularly with EluPro targeting a large market. Financial performance shows improved margins and a solid cash position. Despite risks like regulatory approvals and competition, optimistic guidance and shareholder returns are positive indicators. The Q&A reveals confidence in product adoption and strategic expansion. However, cautious sentiment on pricing and rep count suggests some uncertainty. Overall, the company's strategic initiatives and financial health suggest a positive stock price movement in the short term.
People Also Watch
FAQ
What were the key highlights of ELUT’s latest earnings report for FY2025Q3?
How did ELUT’s stock price react after the FY2025Q3 earnings release?
What are the revenue and EPS estimates for ELUT for 2025/Q4?
How does ELUT’s stock price correlate with earnings forecast revisions?
What should investors expect from ELUT’s next earnings report?